EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SPARC promotes angiogenesis and cell migration via VEGFR2-ERK1/2-SPHK1 axis in pterygium

Yao Xu, Dongyi Yu, Li Wang, Jing Lou, Xinyu Zhuang, Yingjie Chen, Wenli Lin, Xiaofeng Zhang

Experimental Eye Research · 2026

DOI: 10.1016/j.exer.2026.111105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Eye Research, 2026. Verfasst von Yao Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Fourth Affiliated Hospital of Soochow University, No. 9 Chongwen Road, Suzhou, 215000, China. Hauptthemen laut MEDLINE: Pterygium, Osteonectin, Vascular Endothelial Growth Factor Receptor-2, Neovascularization, Pathologic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suzhou Municipal Health Commission, Suzhou City Science and Technology Bureau, Science and Technology Program of Suzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathological angiogenesis is a primary driver of pterygium progression, yet the mechanistic role of Secreted Protein Acidic and Rich in Cysteine (SPARC) remains to be fully elucidated. This study investigated the clinical significance and molecular function of SPARC in pterygium-associated neovascularization. Expression analysis in human pterygium tissues revealed a significant upregulation of SPARC, which positively correlated with lesion microvascular density as assessed by immunofluorescence and anterior segment optical coherence tomography angiography. Functionally, in vitro assays demonstrated that recombinant SPARC treatment robustly enhanced the migration, invasion, and tube-forming capacity of human umbilical vein endothelial cells (HUVECs), alongside elevated expression of the angiogenesis markers CD31 and α-SMA. Transcriptomic sequencing and Gene Set Enrichment Analysis (GSEA) identified a significant enrichment of SPARC-regulated genes within the vascular endothelial growth factor (VEGF) signaling pathway. Mechanistically, SPARC promoted Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) phosphorylation, triggering a sequential activation cascade of Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) and Sphingosine Kinase 1 (SPHK1). This pathway culminated in SPHK1 phosphorylation at Ser225 and increased production of the pro-angiogenic lipid mediator sphingosine-1-phosphate (S1P). Pharmacological inhibition of VEGFR2, ERK1/2, or SPHK1 attenuated these effects. In conclusion, this study provides a mechanistic validation of the SPARC/VEGFR2/ERK/SPHK1 signaling axis that drives pathological angiogenesis in pterygium, highlighting this cascade as a promising therapeutic target for clinical intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PterygiumOsteonectinVascular Endothelial Growth Factor Receptor-2Neovascularization, PathologicAngiogenesisHumansCell MovementHuman Umbilical Vein Endothelial CellsBlotting, WesternFemaleMaleCells, CulturedMiddle AgedMAP Kinase Signaling SystemPhosphorylationMitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase 1Signal TransductionReal-Time Polymerase Chain Reaction

Stichwörter der Autor:innen

AngiogenesisMigrationPterygiumSPARCVEGFR2

Substanzen

OsteonectinVascular Endothelial Growth Factor Receptor-2KDR protein, humanSPARC protein, humanMitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase 1

Autor:innen und Institutionen

  • Department of Ophthalmology, The Fourth Affiliated Hospital of Soochow University, No. 9 Chongwen Road, Suzhou, 215000, China.
  • Department of Ophthalmology, The Fourth Affiliated Hospital of Soochow University, No. 9 Chongwen Road, Suzhou, 215000, China; Department of Ophthalmology, Kunshan First People's Hospital Affiliated to Jiangsu Universit…
  • Department of Ophthalmology, The Fourth Affiliated Hospital of Soochow University, No. 9 Chongwen Road, Suzhou, 215000, China. Electronic address: zhangxiaofeng@suda.edu.cn.

Förderung

  • Suzhou Municipal Health Commission
  • Suzhou City Science and Technology Bureau
  • Science and Technology Program of Suzhou

Zitieren

APA

Xu, Y., Yu, D., Wang, L., Lou, J., Zhuang, X., Chen, Y., Lin, W., & Zhang, X. (2026). SPARC promotes angiogenesis and cell migration via VEGFR2-ERK1/2-SPHK1 axis in pterygium. Experimental Eye Research. https://doi.org/10.1016/j.exer.2026.111105

Vancouver

Xu Y, Yu D, Wang L, Lou J, Zhuang X, Chen Y, et al. SPARC promotes angiogenesis and cell migration via VEGFR2-ERK1/2-SPHK1 axis in pterygium. Experimental Eye Research. 2026. doi:10.1016/j.exer.2026.111105

BibTeX
@article{Xu2026,
  author = {Xu, Yao and Yu, Dongyi and Wang, Li and Lou, Jing and Zhuang, Xinyu and Chen, Yingjie and Lin, Wenli and Zhang, Xiaofeng},
  title = {SPARC promotes angiogenesis and cell migration via VEGFR2-ERK1/2-SPHK1 axis in pterygium},
  journal = {Experimental Eye Research},
  year = {2026},
  doi = {10.1016/j.exer.2026.111105}
}
Kostenlos starten →